MAR 15, 2020 6:03 PM PDT

Immune Cells Can Attack Tumors Remotely

WRITTEN BY: Carmen Leitch

The body's immune system is able to identify the cancerous cells of a tumor and launch an attack against them (the cancerous growth just often overwhelms the body's capabilities). Immunotherapies aim to destroy cancer by enhancing the efficacy of this natural system.

In the video, T lymphocytes (green) attack a tumor (blue and orange). In vivo real-time experiments indicate T lymphocytes act both locally and remotely within the tumor. © Ronan Thibaut and Philippe Bousso, Institut Pasteur / Inserm

Scientists have now learned more about how the immune system tries to limit the growth of tumors. Researchers have used imaging tools on a mouse model to view the movement of immune cells called T lymphocytes as they launched both a local and a remote attack on tumors. The findings have been reported in Nature Cancer.

T lymphocytes can infiltrate tumors and destroy the cancerous cells that they are made of, one by one, using direct contact. This phenomenon is highly localized, and occurs only in the immediate vicinity of these killer T cells. The T lymphocytes produce and release molecules called cytokines. In this research, the scientists aimed to learn more about how one cytokine in particular, called interferon-gamma (IFN-γ), impacts the tumor microenvironment.

The researchers used powerful imaging tools to watch how T lymphocytes behaved in real-time in live mice. They also observed how the IFN-γ was affecting cells within tumors. They saw that the cytokines were not acting locally; they quickly dispersed inside the tumor as well as impacting cells that were farther away from the T cells.

"This remote action within the tumor is very interesting because it enables T lymphocytes to act on a large number of cancer cells, especially those that may have developed mechanisms to escape the immune system," explained the lead study author Philippe Bousso, an Inserm researcher and Head of the Dynamics of Immune Responses Unit at the Institut Pasteur.

The investigators also showed that cytokine levels and the response to the cancer were linked to the number of T lymphocytes that were successfully able to get into the tumor. An analysis of cells from melanoma patients supported the idea that immune cells can act remotely. It may, therefore, be possible to stimulate this response as part of an immunotherapy strategy.

Sources: AAAS/Eurekalert! via Institut Pasteur, Nature Cancer

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
MAR 12, 2020
Cell & Molecular Biology
MAR 12, 2020
Zika Virus Used to Treat Advanced Tumors in Dogs
Researchers found a use for the zika virus; they treated advanced tumors of the central nervous system of three elderly ...
MAR 17, 2020
Genetics & Genomics
MAR 17, 2020
Targeting RNA With CRISPR
Researchers screened thousands of target molecules to find the most effective targets, and have made their data openly a ...
APR 02, 2020
Immunology
APR 02, 2020
Transforming T Cells into Powerful Memory Cells That Target Cancer
New cancer treatments are now based on harnessing the power of the human body’s own immune cells to get the job do ...
APR 13, 2020
Neuroscience
APR 13, 2020
The Memory Cells that Help Us Interpret Different Situations
Neuroscientists from MIT have identified cell populations that encode different parts of an overall experience. Like the ...
APR 27, 2020
Cell & Molecular Biology
APR 27, 2020
Cold Foods Don't Taste as Good, Even to Flies
The deliciousness of a food appeal is about a lot more than just taste.
MAY 10, 2020
Genetics & Genomics
MAY 10, 2020
Towards a Targeted Elimination of Leukemic Cells
Our blood carries many types of critical cells, including platelets, red blood cells, and white blood cells, which are m ...
Loading Comments...